Overview
Swedish AI software developer's Q3 net sales fell 32% yr/yr due to competition and savings
Adjusted EBITDA loss for Q3 narrowed significantly
Company launched Qlucore Omics Explorer 3.11 with protein data support
Outlook
Company is focusing on expanding market presence in diagnostics segment
Qlucore is developing new diagnostic tests within EU-funded projects
Company faces restrictive purchasing behavior due to geopolitical and economic factors
Result Drivers
PRODUCT LAUNCH - Qlucore launched Omics Explorer 3.11 during Q3, focusing on protein data analysis to strengthen its offering
COMPETITION IMPACT - Net sales decline attributed to increased competition from free solutions like open-source projects
DIAGNOSTICS FOCUS - Co is expanding market presence in diagnostics segment, including partnerships with Nordic hospitals
Company press release: ID:nMFN3NXFMf
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
SEK 2.19 mln
Q3 EPS
-SEK 0.08
Q3 Net Income
-SEK 3.31 mln
Q3 Adjusted Free Cash Flow
-SEK 2.56 mln
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)